Achieve Life Sciences (ACHV) Non Operating Income (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Non Operating Income data on file, last reported at $295000.0 in Q1 2026.

• Quarterly Non Operating Income rose 340.3% year-over-year to $295000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $460000.0 (up 356.98% YoY) and the FY2025 annual result came in at $232000.0, up 130.61% from the prior year.
• Non Operating Income grew to $295000.0 in Q1 2026, from $69000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $295000.0 in Q1 2026 to a low of -$1.1 million in Q4 2023.
• A 5-year average of -$255647.1 and a median of -$347000.0 in 2022 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2022 — Non Operating Income sank 22000.0% — and 2025, when it surged 645.65%.
• Tracing ACHV's Non Operating Income over 5 years: stood at -$370000.0 in 2022, then slumped by 194.59% to -$1.1 million in 2023, then soared by 84.4% to -$170000.0 in 2024, then jumped by 140.59% to $69000.0 in 2025, then jumped by 327.54% to $295000.0 in 2026.
• The last three Non Operating Income figures came in at $295000.0 (Q1 2026), $69000.0 (Q4 2025), and $251000.0 (Q3 2025), per Business Quant data.